Sign in to view content

Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2017

Related

Advances in Diabetic Vitrectomy
Judy E. Kim, MD, FASRS
Updates from the Field
2016
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Updates from the Field
2020
APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD
Michael N. Cohen, MD
Updates from the Field
2020

Category: Diabetic Retinopathy

See more